In addition, we also analyzed the transferability of the prognostic relevance of the characteristic gene expression signature that distinguished short- and long-lived DNMT3A-mutated TCGA AML patients (Fig. 2A, Supplementary Table 2, q < 0.1). This evidence concerns the gene DNMT3A and acute myeloid leukemia.